Bright Pink’s Medical Advisory Committee is a group of more than 20 health professionals who are lending their expertise and talents to further our preventive mission. They help create and review our educational resources, provide perspectives on the latest research, and spread our message. Learn more about individual members below.
Banu Arun, MD
Dr. Arun is a professor in the Department of Breast Medical Oncology, Co-Medical Director of the Clinical Cancer Genetics Program and Section Chief Breast Genetics, Prevention and Screening at the University of Texas MD Anderson Cancer Center. Given her national and international expertise she has served in several committees, including The American Society of Clinical Oncology (ASCO) Prevention committee and currently serves as the Co-Chair for the Southwest Oncology Group (SWOG) Prevention and Epidemiology Committee and member of the NCCN Breast Cancer Risk Reduction Guideline Committee, member of the ASCO BOLD task force, member of ASCO IDEA committee, and member of the National Cancer Institute (NCI)Cancer Prevention Steering Committee. She was also featured in Forbes (2017) as one of the top 30 breast medical oncologists in the nation. She completed her medical degree and her residency at the University of Istanbul before serving in a fellowship at the Vincent T. Lombardi Cancer Center at Georgetown University in Washington.
Sonya Bhole, MD
Dr. Bhole is an assistant professor of radiology at Northwestern University. Her research includes a study on MRI-guided breast interventions. She received her medical degree from Virginia Commonwealth University School of Medicine, and completed her residency and fellowship at the McGaw Medical Center of Northwestern University.
Josh Cohen, MD
Dr. Cohen is a gynecologic oncologist with specialized training in gynecologic cancer treatment as well as clinical care and research currently working at UCLA Health. He has completed the Clinical Research Training Program at the National Institutes of Health as well as the Clinical and Translational Science Institute certificate program at the David Geffen School of Medicine at UCLA. His research interests include the treatment of recurrent ovarian cancer and patient-centered outcomes in gynecologic oncology. Dr. Cohen completed medical school at Northwestern University and his OB/GYN residency at the University of California San Francisco. He completed a fellowship in the treatment of women with gynecologic cancers including patients at high risk for ovarian and uterine cancers related to genetic mutations or strong family history, as well as unknown etiology and concern for possible malignancy or difficult resection.
Laura Esserman, MD, MBA
Dr. Esserman is a surgeon and breast cancer oncology specialist practicing at the UCSF Carol Franc Buck Breast Care Center where she has also held the position of Director since 1996. She co-leads the Breast Oncology Program, and is a professor of Surgery & Radiology at UCSF and faculty at the UCSF Helen Diller Family Comprehensive Cancer Center where she founded the program in Translational Informatics. Dr. Esserman is nationally and internationally known as a leader in the field of breast cancer and speaks extensively at public and private forums within the U.S. and internationally. Overall, Dr. Esserman’s research and writing tends to focus on the goal of giving patients better access to accurate information so that they can become partners in their health care. She completed her medical degree, residency in surgery, and fellowship in oncology at Stanford University.
Elizabeth Etkin-Kramer, MD
Dr. Etkin-Kramer is the Past President of the Dade County Medical Association (2012-2013) and is currently an officer in the Florida District XII of the American College of Obstetrics and Gynecology. She is a clinical instructor in gynecology for the Miami Dade College Physician Assistant program and holds a voluntary role as assistant professor of OB/GYN at both the University of Miami’s Leonard P. Miller School of Medicine and Florida International University School of Medicine. In addition, she is the medical director of South Florida Research Associates. She completed her medical degree at the University of Florida School of Medicine in Gainesville, Florida followed by a four-year residency training program at Jackson Memorial Hospital University of Miami School of Medicine.
Melissa Fana, MD
Dr. Fana is a Breast Surgical Oncologist who focuses on malignant and benign breast disease. She also works to identify women at risk for breast and ovarian cancer through genetic mutation and elevated lifetime risk. Her surgical technical expertise includes nipple sparing mastectomy, as well as oncoplastically focused breast conservation. Dr. Fana received her medical degree from Mount Sinai School of Medicine and completed a residency at North Shore University Hospital and a fellowship at William Beaumont Hospital of Royal Oak.
Mary E. Freivogel, CGC
Mary E. Freivogel, MS, CGC, is a Past President of the National Society of Genetic Counselors. As a cancer genetic counselor, her recent career path has been focused primarily on breast cancer risk assessment and cancer genetic counseling within the setting of a high-volume breast imaging center. Starting in February 2019, she began a role with Invitae, where she leads marketing efforts directed towards clinicians in the United States. Mary is passionate about the genetic counseling profession and takes a special interest in the areas of efficiency and alternative models of service delivery. She believes wholeheartedly that genetic counselors have an infinite number of talents and unique contributions to provide to clinical care, research, teaching, industry, and countless other areas.
Elizabeth Hibler, PhD, MPH
Dr. Hibler is an Assistant Professor in the Department of Preventive Medicine at Northwestern University Feinberg School of Medicine. She is a cancer and molecular epidemiologist conducting research focused on identifying risk factors for cancer among high-risk populations and the risk of chronic disease among cancer survivors. Specific studies include: 1) the relationship between device-based measures of physical activity and high breast density, 2) the impact of Bright Pink’s Assess Your Risk on breast and ovarian cancer prevention, and 3) predicting the risk of cardiovascular disease among young adult breast cancer survivors. This work seeks to understand the intricate relationships between health behaviors, biological mechanisms, and cancer or other chronic disease outcomes among high-risk populations. She received her doctorate at the University of Arizona and postdoctoral training at the University of Arizona Cancer Center and Vanderbilt University.
Kent Hoskins, MD
Dr. Hoskins is a VST Associate Professor in the Department of Medicine in the division of Hematology and Oncology at the University of Illinois College of Medicine. As the director of the UIC Familial Breast Cancer Program, he focuses on the assessment of breast cancer risk. Utilizing both population studies and molecular approaches, he has developed strategies to reduce breast cancer mortality by better identifying high-risk individuals. He also examines the disparity in breast cancer mortality between Black and African American women and those of other racial demographics, paying particular attention to environmental factors that lead to the development of aggressive breast cancer. Dr. Hoskins completed both his medical education and his residency at the University of Iowa, specializing in internal medicine.
Michael Howard, MD
Dr. Howard has long been a Bright Pink supporter, thanks to personal ties to breast cancer prevention. He works as a plastic surgeon for Northwestern Medicine in Lake Forest, IL, where he specializes in several procedures, including breast surgery and breast cancer reconstruction. Dr. Howard graduated from Emory University of Medicine before completing his residency at MedStar Health, affiliated with Georgetown University. He then served as a fellow at the Memorial Sloan Kettering Cancer Center.
Charles “Tre” Leath III, MD, MSPH, ACOG, ACS
Dr. Leath is the Ellen Gregg Shook Culverhouse Chair in Gynecologic Oncology and Tenured Professor at the University of Alabama at Birmingham. He is also Chair of the NRG Oncology Cervical & Vulvar Cancer Committee and a member of the Safety Committee. Dr. Leath is actively involved in clinical research in the management of cervical and ovarian cancers, as well as clinical trials for all aspects of gynecologic cancer, and currently serves as the National Principal Investigator for NRG clinical trial GY006 evaluating the addition of triapine to standard chemoradiation for locally advanced cervical cancer. He received his medical degree from the Medical University of South Carolina, and completed an OB/GYN residency and gynecologic oncology fellowship at the University of Alabama at Birmingham.
Anjali Malik, MD
Dr. Malik practices as a Breast Imaging and Intervention Specialist at Washington Radiology, serving patients of the DC Metroplex. She is also the Co-Chair for Social Media for the Society of Breast Imaging, a member of the Breast Economics Committee for the American College of Radiology, and the Chair of the Women & Diversity for the District of Columbia Metropolitan Radiological Society. Her passions are breast imaging, women’s health, global health, preventive medicine, and healthy, eco-friendly living. Dr. Malik received her medical degree from Tulane University School of Medicine and completed her residency at The University of Texas Southwestern Medical Center/Parkland Hospital and Health in Dallas, TX. She had the honor of being a Brem Fellow in Breast Imaging and Intervention at The George Washington University Medical Faculty Associates.
Wendy Goodall McDonald, MD, FACOG
Dr. McDonald is in practice at Women’s Health Consulting, IL, LLC and Prentice Women’s Hospital. Also known as Dr. Every Woman, Dr. Wendy is the founder and Editor-in-Chief of The Gyneco-blogic, a health blog that combines education and fun. She also doubles as an author, singer, and rapper, rising as the Weird Al of women’s health. She is a rising medical influencer across all social media platforms including Instagram, Twitter, Facebook and YouTube under the keyword, @dreverywoman. Dr. McDonald graduated from Northwestern University Feinberg School of Medicine and completed her residency at Rush University Medical Center.
Heidi Memmel, MD, FACS
Dr. Memmel is the Surgical Director of the Caldwell Breast Center at Advocate Lutheran General Hospital, where she has been in practice for over thirteen years. She founded and oversees the Risk Assessment and Prevention Program and takes particular interest in helping to identify women at increased risk, and counselling them in screening and risk reduction options. She also specialises in treating breast cancer in young women and during pregnancy. She received her medical degree from Northwestern University before completing a General Surgery residency at University of Illinois Chicago Metropolitan Program. She completed her breast surgery fellowship at Northwestern University’s Lynn Sage Breast Center.
Sara Roper, MD
Dr. Roper currently works in private practice as an OB/GYN at a community hospital in Beaver, PA. She has a passion for empowering women to take control of their health and arming them with tools for prevention and wellness. Zeta Tau Alpha introduced Dr. Roper to Bright Pink soon after she became an initiated sister. She is excited to work with an organization that has a mission so similar to her own. Dr. Roper graduated from Geisinger Commonwealth School of Medicine and completed her residency at TriHealth in Cincinnati, Ohio.
Amber Trivedi, CGC
Now the Chief Innovation Officer at Informed DNA, Amber Trivedi has supported Bright Pink since the organization’s founding in 2007. Amber has several years of experience working as a genetic counselor and even more working for Informed DNA, a company that helps health professionals, systems, and patients understand and use genetic testing appropriately. She graduated from Johns Hopkins with a degree in behavioral biology before completing her master’s in genetic counseling from Northwestern University’s Feinberg School of Medicine.
Allison H West DePersia, MD
Dr. DePersia is a medical oncologist specializing in clinical cancer genetics at NorthShore University HealthSystem’s Mark R. Neaman Center for Personalized Medicine. Dr. DePersia is a member of the High Risk Breast team at NorthShore who has expertise in hereditary cancer syndromes and cancer risk and screening. In her clinical practice she sees patients for cancer genetic testing and provides long term follow-up for cancer screening and prevention. Her research includes refining risk assessment and screening approaches for patients who may be at an elevated risk for breast cancer and other cancers. Dr. DePersia is board certified in medical oncology and internal medicine. She earned her medical degree from New York University School of Medicine and completed a residency and fellowship at the University of Chicago Hospitals.
Carmen Williams, CGC
Carmen Williams is a genetic counselor in the Saint Luke’s Health System in Kansas City. She started her career in genetic counseling as a member of the cancer genetics team at the University of Michigan. While there she gained experience in cancer risk assessment and coordination of medical management for a broad range of genetic syndromes including Lynch syndrome, polyposis conditions (FAP, JPS, PJS), Li-Fraumeni syndrome, and Von Hippel-Lindau disease. In 2015 she joined the Northwestern Cancer Genetics Program where she provided hereditary cancer risk assessment and counseling. She then served as the Lead Genetic Counselor of the Cancer Genetics program at Northwestern Medical Group and an instructor in the Feinberg School of Medicine. During her time there she was a member of the OncoSET tumor sequencing program at Northwestern helping integrate personalized medicine in a variety of oncology specialties.
Meltem Zeytinoglu, MD
Dr. Zeytinoglu’s clinical practice emphasizes management and prevention of endocrine disorders in older adults, including diabetes, osteoporosis, and obesity. Having personally navigated the painful and heavy experience of early-onset high risk breast cancer, she is grateful for Bright Pink’s mission, and for the opportunity to be an advocate for young women. Her interests also include health policy to improve healthcare delivery systems, access to care for women and coordination of care among providers. Dr. Zeytinoglu received her medical degree from the Indiana University of Medicine and completed her internship and residency through the University of Chicago Northshore University Program.